Education, Science, Technology, Innovation and Life
Open Access
Sign In

The Influence of Patient Capital on the Cost of Debt

Download as PDF

DOI: 10.23977/accaf.2026.070101 | Downloads: 7 | Views: 168

Author(s)

Jing Zhang 1, Kai Tang 1

Affiliation(s)

1 School of Economics and Management, Taizhou University, Taizhou, 225300, China

Corresponding Author

Kai Tang

ABSTRACT

This study empirically investigates the impact of patient capital on the cost of debt based on a sample of A-share listed companies in China from 2009 to 2024. We find that the patience capital reduces the firms’ cost of debt by improving corporate governance and increasing firm value. After controlling for heteroscedasticity and endogeneity, our conclusions remain valid. Our study further expands the study on the economic consequences of patient capital and reveals that patient capital can reduce corporate debt financing costs, thereby emphasizing that the government should encourage the development of patient capital. Furthermore, our study also provides practical guidance for reducing corporate financing costs.

KEYWORDS

Patient capital, Cost of debt, Corporate governance, Firm value

CITE THIS PAPER

Jing Zhang, Kai Tang. The Influence of Patient Capital on the Cost of Debt. Accounting, Auditing and Finance (2026). Vol. 7, No.1, 1-7. DOI: http://dx.doi.org/10.23977/accaf.2026.070101.

REFERENCES

[1] Chu, P. and Zhang, R. (2025) Research on the Impact of Patient Capital on Enterprise Resilience. Modern Economic Research, (08), 80-94.
[2] Liu, X. and Chen, S. Z. (2025) Research on the Relationship between Patient Capital, Asset Liquidity and High-Quality Development of Enterprises. Price: Theory & Practice, (05), 178-184.
[3] Yao, J., Qi, Y. and Guo, B. (2022) Corporate Social Responsibility, Debt Financing Cost and Enterprise Innovation. Scientific Reports, 12, 21909.
[4] Hu, H. F., Zhang, Y. and Wang, A. P. (2025) New Research Progress on the Patient Capital. Economic Perspectives, (07), 192-208.
[5] Lin, Y. F. and Wang, Y. (2017) New Structural Economics: Treating 'Patient Capital' as a Comparative Advantage. Development Finance Research, 11(01), 3-15.
[6] Ran, L. (2025) An Exploration of Patient Capital on Enterprise Digital Transformation. Accounting and Corporate Management, 7(3) , 80-83.
[7] Wu, M. J., Zhang, P. and Zhao, Z. Y. (2022) The Impact of Patient Capital and Innovation Investment on Corporate Performance: Based on the Data of Small and Medium-sized Board Listed Companies. Scientific Decision Making, (09), 55-72.
[8] Aghion, P., Reenen,V. J. and Zingales, L. (2013) Innovation and Institutional Ownership. The American Economic Review, 103(1), 277-304.
[9] Liu, B. and Lu, J. R. (2024) Does the Quantity of ESG Information Disclosure Reduce the Cost of Corporate Debt Financing?. Studies of International Finance, (06), 87-96.
[10] Xu, Q., Ruan, C., Jiang, C. and Li, L. (2025) The Spillover Effect of Core Enterprises' ESG Performance on Node Enterprises' Debt Financing Costs. Global Finance Journal, 68, 101208.
[11] Wang, C. H. (2024) Analysis of the Impact of Accounting Conservatism on Corporate Debt Financing Cost. Vitality, 42(05), 7-9.
[12] Guan, Z. Z. and Wang, Y. W. (2023) The Impact of Corporate Social Responsibility on Debt Financing Cos-A Mechanism Effect Based on Default Risk. Price: Theory & Practice, (08), 135-138+209.
[13] Li, J. J. (2022) Internal Control Quality, Financing Environment, and Debt Financing Cost. Communication of Finance and Accounting, (14), 74-77.
[14] Tang, L., Tong, M. X. and Yang, G. Y. (2026) Impact of Patient Capital Investment on Supply Chain Resilience. East China Economic Management, 40(01), 50-62.
[15] Yan, A. Q. (2025) Research on the Influence Mechanism and Pathways of Patient Capital on Corporate Long-Term Value Creation. Friends of Accounting, (22), 76-84.
[16] Shi, Y., Zheng, S., Xiao, P., Zhen, H. and Wu, T. (2024) ESG Performance and Cost of Debt. China Journal of Accounting Research, 17(4), 100390.
[17] Qiu, R., Tian, Z., Mai, J. and Ding, R. (2024) Patient Capital and the Improvement of Enterprise Total Factor Productivity. Securities Market Herald, (12), 3-12.

Downloads: 13371
Visits: 245866

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.